WOODCLIFF LAKE, N.J. Generic drug maker Par Pharmaceutical Cos. has appointed a former Roche executive to its board of directors, Par said Thursday.
Par announced the appointment of Patrick Zenner, whom it also appointed to two executive committees. Zenner retired in 2001 from Hoffman-La Roche North America, where he had worked for 32 years, including eight years as president and CEO. Currently, he is board chairman of ArQule and Exact Sciences Corp. and a director of West Pharmaceutical Services, as well as a trustee of Creighton University.
“I am very pleased to welcome an executive of Pat’s caliber to our board,” Par CEO Patrick LePore said. “He has a detailed knowledge of the pharmaceutical industry and has extensive board experience.”